Ronald Blue Trust, Inc. Pfizer Inc Transaction History

Ronald Blue Trust, Inc.

$7.98 Billion
Q3 2024

A detailed history of Ronald Blue Trust, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 53,559 shares of PFE stock, worth $1.42 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

53,559

Previous 50,457 6.15%

Holding current value

$1.42 Million

Previous $1.41 Million 9.78%

% of portfolio

0.02%

Previous 0.02%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$27.7 - $31.39 $85,925 - $97,371	3,102 Added 6.15%	53,559 $1.55 Million
Q2 2024 Jul 18, 2024	BUY	$25.26 - $29.6 $129,735 - $152,025	5,136 Added 11.33%	50,457 $1.41 Million
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $1.06 Million - $1.22 Million	-40,984 Reduced 47.49%	45,321 $1.26 Million
Q4 2023 Jan 18, 2024	SELL	$26.13 - $33.94 $44,603 - $57,935	-1,707 Reduced 1.94%	86,305 $2.86 Million
Q3 2023 Oct 11, 2023	BUY	$32.09 - $37.51 $1.21 Million - $1.42 Million	37,827 Added 75.38%	88,012 $3.23 Million
Q2 2023 Jul 14, 2023	SELL	$36.12 - $41.79 $379,801 - $439,421	-10,515 Reduced 17.32%	50,185 $2.05 Million
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $92,842 - $120,866	-2,357 Reduced 3.74%	60,700 $3.11 Million
Q4 2022 Jan 17, 2023	BUY	$41.75 - $54.5 $308,449 - $402,646	7,388 Added 13.27%	63,057 $2.76 Million
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $148,696 - $181,521	3,398 Added 6.5%	55,669 $2.92 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $2.43 Million - $2.88 Million	52,271 New	52,271 $2.71 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.

Account

Ronald Blue Trust, Inc. Pfizer Inc Transaction History